Xeris Biopharma Holdings, Inc. Common Stock (XERS) Stock Price
Xeris Biopharma Holdings, Inc. Common Stock (NASDAQ: XERS) last traded at $8.70, up 1.16% on the session. The quote above updates while this page is open; the figures below are drawn from Xeris Biopharma Holdings, Inc. Common Stock’s own filings and are restated only when a new one is published.
Xeris Biopharma Holdings, Inc. Common Stock (XERS) company overview
Xeris Biopharma Holdings, Inc. Common Stock trades on NASDAQ under the ticker XERS. Its market capitalisation is $1.59 billion.
XERS valuation
Valuation measures for Xeris Biopharma Holdings, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$1.59B
Enterprise value
$1.89B
Price / sales
4.73
Beta
0.77
XERS financials
Trailing-twelve-month figures tagged in Xeris Biopharma Holdings, Inc. Common Stock's XBRL filings with the SEC.
Revenue (TTM)
$335.41M
Net income (TTM)
-$17.16M
EPS (TTM)
-$0.100
Operating margin
10.91%
Cash
$121.75M
XERS trading statistics
Range and volume for XERS over the past 52 weeks.
52-week high
$10.08
52-week low
$5.25
Volume
1.46M
Average volume
1.89M
Previous close
$8.60
Xeris Biopharma Holdings, Inc. Common Stock (XERS) FAQs
What is the XERS stock price today?
Xeris Biopharma Holdings, Inc. Common Stock (XERS) last traded at $8.70, up 1.16% on the session. FurlPay quotes XERS from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is XERS listed on?
Xeris Biopharma Holdings, Inc. Common Stock is listed on NASDAQ under the ticker symbol XERS.
What is Xeris Biopharma Holdings, Inc. Common Stock's market cap?
Xeris Biopharma Holdings, Inc. Common Stock has a market capitalisation of $1.59 billion, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is XERS's 52-week range?
Over the past 52 weeks XERS has traded between $5.25 and $10.08.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001867096), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
XERS Stock Price & Quote | Xeris Biopharma Holdings, Inc. Common Stock | FurlPay